Published in Folia Morphol (Warsz) on May 01, 2004
Decellularized scaffolds in regenerative medicine. Oncotarget (2016) 0.75
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol (2012) 1.44
Arterial wall lymphangiogenesis is increased in the human iliac atherosclerotic arteries: involvement of CCR7 receptor. Lymphat Res Biol (2014) 1.42
Increased risk of thyroid pathology in patients with thyroid hemiagenesis: results of a large cohort case-control study. Eur J Endocrinol (2009) 1.28
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother (2013) 1.16
Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines. Biomed Pharmacother (2013) 1.14
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. Clin Cancer Res (2006) 1.08
Intracellular localization of NS3 and C proteins in chronic hepatitis C. Liver Int (2005) 1.08
Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance. Breast Cancer Res (2005) 1.07
MDR gene expression analysis of six drug-resistant ovarian cancer cell lines. Biomed Res Int (2012) 1.07
Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients. Virchows Arch (2005) 1.06
In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. Food Chem Toxicol (2012) 0.99
Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Pol J Pathol (2007) 0.99
LAM cells biology and lymphangioleiomyomatosis. Folia Histochem Cytobiol (2013) 0.99
Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol (1985) (2005) 0.99
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival. Pathol Oncol Res (2011) 0.98
Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor. Anticancer Res (2007) 0.97
Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology (2011) 0.96
Development of porcine model of chronic tachycardia-induced cardiomyopathy. Int J Cardiol (2010) 0.94
CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients. Anticancer Res (2007) 0.94
Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers. Folia Histochem Cytobiol (2006) 0.94
Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma. Anticancer Res (2011) 0.93
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome. Virchows Arch (2007) 0.91
Endothelial integrity of radial artery grafts harvested by minimally invasive surgery--immunohistochemical studies of CD31 and endothelial nitric oxide synthase expressions: a randomized controlled trial. Eur J Cardiothorac Surg (2010) 0.89
CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases. Anticancer Res (2006) 0.89
Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol (2007) 0.88
Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients. J Histochem Cytochem (2004) 0.88
Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma. Folia Histochem Cytobiol (2004) 0.87
Significance of podoplanin expression in cancer-associated fibroblasts: a comprehensive review. Int J Oncol (2013) 0.87
Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas. Anticancer Res (2008) 0.86
Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J Pineal Res (2013) 0.86
Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients. Virchows Arch (2007) 0.86
Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol (2012) 0.85
Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2). In Vivo (2007) 0.85
Influence of pressure on the endothelium of the saphenous vein coronary artery bypass graft. In Vivo (2007) 0.85
Development of foreign body giant cells in response to implantation of Spongostan as a scaffold for cartilage tissue engineering. In Vivo (2008) 0.85
Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer. Anticancer Res (2011) 0.85
The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions. Folia Morphol (Warsz) (2004) 0.85
Effect of melatonin on human keratinocytes and fibroblasts subjected to UVA and UVB radiation In vitro. In Vivo (2009) 0.84
The role of periostin in neoplastic processes. Folia Histochem Cytobiol (2015) 0.84
Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue. Int J Oncol (2012) 0.84
Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study. Folia Histochem Cytobiol (2013) 0.84
Expression of metallothionein-III in patients with non-small cell lung cancer. Anticancer Res (2013) 0.84
FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid. Horm Res Paediatr (2011) 0.84
Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients. Oncol Rep (2007) 0.84
Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. Molecules (2010) 0.84
MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. Glycobiology (2012) 0.84
Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Anticancer Res (2008) 0.83
Induction of apoptosis by EGCG in selected tumour cell lines in vitro. Folia Histochem Cytobiol (2003) 0.83
Real-time proliferation of porcine cumulus cells is related to the protein levels and cellular distribution of Cdk4 and Cx43. Theriogenology (2013) 0.83
Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J Pineal Res (2003) 0.83
Nuclear localization of aldolase A correlates with cell proliferation. Biochim Biophys Acta (2013) 0.82
Short-term cultivation of porcine cumulus cells influences the cyclin-dependent kinase 4 (Cdk4) and connexin 43 (Cx43) protein expression--a real-time cell proliferation approach. J Reprod Dev (2013) 0.82
Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury. Thromb Haemost (2012) 0.82
Prognostic significance of nuclear and cytoplasmic expression of metallothioneins as related to proliferative activity in squamous cell carcinomas of oral cavity. Histol Histopathol (2008) 0.82
Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor. Histol Histopathol (2008) 0.81
Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers. Folia Histochem Cytobiol (2010) 0.81
Correlation of metallothionein expression with clinical progression of cancer in the oral cavity. Anticancer Res (2009) 0.81
[Expression of survivin, SDF-1 and CXCR4 on tumor cells in ovarian cancer]. Ginekol Pol (2010) 0.81
[Disturbance of gene expression in endometrial cancer as therapy aim]. Ginekol Pol (2011) 0.81
The immunohistochemical demonstration of parafollicular cells and evaluation of calcium-phosphate balance in patients with thyroid hemiagenesis. Folia Histochem Cytobiol (2011) 0.81
Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res (2006) 0.81
Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications. Hum Vaccin Immunother (2012) 0.81
Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma. Cell Oncol (Dordr) (2013) 0.81
Role of lymphangiogenesis in lung cancer. Folia Histochem Cytobiol (2009) 0.81
Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer. Anticancer Res (2012) 0.81
The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - an immunohistochemical study. J Crohns Colitis (2012) 0.81
Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells. Bioorg Med Chem Lett (2009) 0.81
Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics. Anticancer Res (2005) 0.81
Predictive factors of late venous aortocoronary graft failure: ultrastructural studies. PLoS One (2013) 0.81
The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum. Anticancer Res (2009) 0.81
Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome. Acta Biochim Pol (2013) 0.80
Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res (2007) 0.80
The morphological analysis of vasculature in thyroid tumours: immunoexpression of CD34 antigen. Folia Histochem Cytobiol (2004) 0.80
Melatonin: adjuvant therapy of malignant tumors. Med Sci Monit (2008) 0.80
Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers. Cancer Lett (2005) 0.80
Expression of Breast Cancer Resistance Protein (BCRP-1) in canine mammary adenocarcinomas and adenomas. In Vivo (2009) 0.80
Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. Folia Histochem Cytobiol (2010) 0.80
Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients. Pol J Pathol (2005) 0.80
Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis. Pathol Oncol Res (2012) 0.80
Cytokeratin 8 in venous grafts: a factor of unfavorable long-term prognosis in coronary artery bypass grafting patients. Cardiol J (2013) 0.79
Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course. Virchows Arch (2003) 0.79
Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines. Folia Histochem Cytobiol (2012) 0.79
Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I/II, MT-III) expression in relation to clinicopathological data in ovarian cancer. Anticancer Res (2013) 0.79
Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer. Int J Oncol (2013) 0.79
Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies. In Vivo (2009) 0.79
Expression of metallothionein I/II and Ki-67 antigen in various histological types of basal cell carcinoma. Folia Histochem Cytobiol (2012) 0.79